<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Medicine (Baltimore)</journal-id><journal-id journal-id-type="iso-abbrev">Medicine (Baltimore)</journal-id><journal-id journal-id-type="pmc-domain-id">2786</journal-id><journal-id journal-id-type="pmc-domain">medicine</journal-id><journal-id journal-id-type="publisher-id">MD</journal-id><journal-title-group><journal-title>Medicine</journal-title></journal-title-group><issn pub-type="ppub">0025-7974</issn><issn pub-type="epub">1536-5964</issn><publisher><publisher-name>Wolters Kluwer Health</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12431734</article-id><article-id pub-id-type="pmcid-ver">PMC12431734.1</article-id><article-id pub-id-type="pmcaid">12431734</article-id><article-id pub-id-type="pmcaiid">12431734</article-id><article-id pub-id-type="pmid">39252319</article-id><article-id pub-id-type="doi">10.1097/MD.0000000000039524</article-id><article-id pub-id-type="publisher-id">MD-D-24-06111</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>7300</subject></subj-group><subj-group><subject>Research Article</subject><subject>Observational Study</subject></subj-group></article-categories><title-group><article-title>Mendelian insights: Irritable bowel syndrome as a predictor of upper urinary tract calculi</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="S">Shang</given-names></name><degrees>MMed</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="aff2" ref-type="aff">b</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3847-4864</contrib-id><name name-style="western"><surname>Tian</surname><given-names initials="R">Renli</given-names></name><degrees>MD</degrees><xref rid="aff1" ref-type="aff">a</xref><xref rid="c1" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Department of Urology, General Hospital of Northern Theater Command, Shenyang, Liaoning, P. R. China</aff><aff id="aff2"><label>b</label>Department of Graduate School, China Medical University, Shenyang, Liaoning, P. R. China.</aff></contrib-group><author-notes><corresp id="c1"><label>*</label>Correspondence: Renli Tian, Department of Urology, General Hospital of Northern Theater Command, Shenyang, Liaoning 110016, P. R. China (e-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="tianrenli@aliyun.com">tianrenli@aliyun.com</email>).</corresp></author-notes><pub-date pub-type="collection"><day>06</day><month>9</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>06</day><month>9</month><year>2024</year></pub-date><volume>103</volume><issue>36</issue><issue-id pub-id-type="pmc-issue-id">470382</issue-id><elocation-id>e39524</elocation-id><history><date date-type="received"><day>05</day><month>6</month><year>2024</year></date><date date-type="received"><day>15</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>09</day><month>8</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>09</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 17:25:36.317"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC)</ext-link>, where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="medi-103-e39524.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="medi-103-e39524.pdf"/><abstract><p>Patients with irritable bowel syndrome (IBS) have a notably higher rate of consultations in urology clinics compared to other clinics. They often present with symptoms such as lumbar pain, dysuria, and urinary difficulty that are also associated with upper urinary tract calculi (UUTC). UUTC are the leading cause of nephrectomy in non-oncological cases, early screening for high-risk populations is deemed necessary. We investigated the relationship between IBS and UUTC using a two-sample Mendelian randomization (MR) approach, with the primary analysis conducted using the inverse variance weighting method. To enhance the robustness of our findings, we conducted sensitivity analyses employing Cochran Q test, MR-Egger intercept, and MR-PRESSO. Additionally, we included type 2 diabetes in a multivariate Mendelian randomization analysis for further exploration. Our two-sample MR analysis, employing the inverse variance weighting method, suggested a positive association between IBS and UUTC, with an odds ratio of 1.47, a 95% confidence interval from 1.01 to 2.15, and a <italic toggle="yes">P</italic>-value of .442. Both weighted median and MR Egger analyses also indicated that IBS may be a risk factor for UUTC, although the results were not statistically significant. The Cochran Q test revealed no evidence of heterogeneity (<italic toggle="yes">P</italic>&#8197;&gt;&#8197;<italic toggle="yes">.05</italic>). The MR-Egger intercept and MR-PRESSO analyses did not support the presence of pleiotropy (<italic toggle="yes">P</italic>&#8197;&gt;&#8197;<italic toggle="yes">.05</italic>), and no outliers were detected by MR-PRESSO. Sensitivity analyses reinforce the reliability of our findings. Multivariate MR analysis further confirmed that IBS is a risk confirmed factor for UUTC, with significant results (<italic toggle="yes">P&#8197;&lt;&#8197;.05</italic>). IBS is identified as one of the etiological factors for UUTC, enhancing our understanding of the gut-kidney axis. The specific mechanisms underlying this association warrant further investigation. Clinicians should consider the importance of monitoring for UUTC in patients with IBS.</p></abstract><kwd-group><kwd>FinnGen</kwd><kwd>irritable bowel syndrome</kwd><kwd>Mendelian randomization</kwd><kwd>upper urinary tract calculi</kwd></kwd-group><funding-group><award-group id="ID0E4UAG125321"><funding-source><institution-wrap><institution>Natural Science Foundation of Liaoning Province</institution><institution-id institution-id-type="doi">10.13039/501100005047</institution-id></institution-wrap></funding-source><award-id>2022-MS-047</award-id><principal-award-recipient>Not Applicable</principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>SDC</meta-name><meta-value>T</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro"><title>1. Introduction</title><p>Irritable bowel syndrome (IBS) is characterized by chronic abdominal pain and alterations in bowel movement patterns.<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup> A meta-analysis incorporating data from 8 international studies estimated that the pooled prevalence of IBS was 11%, with substantial variation observed across different regions.<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup> Associations between IBS and certain urinary system conditions have been established. Francis et al<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup> compared the prevalence of IBS among patients in urology clinics and control clinics. They found that IBS was more prevalent in urology clinics (31.2%) than in control clinics (21.2%). The study further observed a higher incidence of IBS in individuals with complaints of flank pain, painful urination, and urinary frequency or urgency symptoms. These symptoms appear to be attributed to urinary tract infections (UTI) or upper urinary tract calculi (UUTC). UUTC is a common issue in primary healthcare settings. Simultaneously, UUTC and loss of follow-up are the major risk factors for renal insufficiency.<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> However, there is a scarcity of observational studies specifically examining the relationship between UUTC and IBS. Observational studies can be influenced by confounding variables, the issue of reversed causality, and multiple biases, making the causal relationships they establish unreliable. Mendelian randomization (MR) is based on the random assortment of alleles during the formation of gametes.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup> This results in the genetic variations being distributed in the population, which are usually independent of behavioral and environmental factors that confuse the epidemiological link between hypothetical risk factors and disease.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup> In certain instances, this can provide research designs that closely resemble those of randomized comparisons.<sup>[<xref rid="R5" ref-type="bibr">5</xref>,<xref rid="R6" ref-type="bibr">6</xref>]</sup></p><p>Therefore, we aimed to investigate the potential causal link between IBS and UUTC risk through MR analysis.</p></sec><sec sec-type="methods"><title>2. Materials and methods</title><p>Since the study involves a reanalysis of existing published data, this study does not require additional ethical approval.</p><sec><title>2.1. Study design</title><p>A two-sample MR study was conducted to explore the causal link between IBS and UUTC. The selection of SNPs as instrumental variables (IVs) adhered to 3 assumptions<sup>[<xref rid="R7" ref-type="bibr">7</xref>]</sup>: (1) a strong genetic correlation between the SNPs and IBS, (2) SNPs should not be associated with any confounding variables, and (3) no direct genetic association of the SNPs with UUTC. Additionally, we incorporated type 2 diabetes<sup>[<xref rid="R8" ref-type="bibr">8</xref>]</sup> into a multivariable analysis to ascertain whether IBS can lead to UUTC (Fig. <xref rid="F1" ref-type="fig">1</xref>).</p><fig position="float" id="F1" orientation="portrait"><label>Figure 1.</label><caption><p>Three hypotheses for a two-sample Mendelian randomization study and multivariate analysis incorporating type 2 diabetes and IBS. IBS = irritable bowel syndrome; UUTC = upper urinary tract calculi.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="medi-103-e39524-g001.jpg"/></fig></sec><sec><title>2.2. Data source</title><p>In this study, we established a relationship between IBS and the incidence of UUTC, with IBS serving as the exposure factor and UUTC as the outcome. The SNPs associated with IBS, identified by the query code ebi-a-GCST90016564, were derived from the GWAS study by Chris Eijsbouts and colleagues,<sup>[<xref rid="R9" ref-type="bibr">9</xref>]</sup> available for consultation at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://gwas.mrcieu.ac.uk/" ext-link-type="uri">https://gwas.mrcieu.ac.uk/</ext-link>. This database contains data on 486,601 samples, with 9739,966 SNPs collected in the exposure dataset. Additionally, SNPs related to type 2 diabetes (query code: ebi-a-GCST006867) provided by Angli Xue and others<sup>[<xref rid="R10" ref-type="bibr">10</xref>]</sup> from their GWAS study, are also available on the same website. The GWAS data for UUTC, utilized as the outcome variable in our study, were obtained from the R10 release by the FinnGen consortium.<sup>[<xref rid="R11" ref-type="bibr">11</xref>]</sup></p></sec><sec><title>2.3. Instrument variable selection</title><p>The selection criteria for IVs to evaluate the impact of IBS on outcomes in our study included: (1) SNPs associated with IBS that reached the locus-wide significance threshold (<italic toggle="yes">P</italic>&#8197;&lt;&#8197;5.0&#8197;&#215;&#8197;10<sup>&#8208;8</sup>) were considered as potential IVs. (2) To mitigate the effects of linkage disequilibrium, we applied the clumping method to isolate independent SNPs, requiring an <italic toggle="yes">r</italic>&#178;&#8197;&lt;&#8197;0.001 and a minimum distance of over 10,000&#8201;kb. (3) We excluded intermediate allele palindromic SNPs from our analysis. (4) The F-statistic was calculated as <italic toggle="yes">F</italic>&#8197;=&#8197;(R<sup>2</sup> * (n&#8197;&#8208;&#8197;<italic toggle="yes">k</italic>&#8197;&#8208;&#8197;1))/(<italic toggle="yes">k</italic> * (1&#8197;&#8208;&#8197;<italic toggle="yes">R</italic><sup>2</sup>)), with <italic toggle="yes">R</italic><sup>2</sup>&#8197;=&#8197;2 * (1&#8197;&#8208;&#8197;MAF) * MAF * (beta/SD)<sup>2</sup>. In this context, n denotes the sample size, <italic toggle="yes">k</italic> represents the number of SNPs, MAF indicates the minor allele frequency (similar to EAF in <italic toggle="yes">R</italic><sup>2</sup> calculation), beta signifies the allele effect size, and SD stands for the standard deviation.<sup>[<xref rid="R12" ref-type="bibr">12</xref>]</sup> An F-value &gt;10 is often regarded as indicative of strong instrumental variables.</p></sec><sec><title>2.4. Statistical analysis</title><p>In our two-sample MR analysis, we utilized inverse variance weighting (IVW),<sup>[<xref rid="R13" ref-type="bibr">13</xref>,<xref rid="R14" ref-type="bibr">14</xref>]</sup> MR-Egger,<sup>[<xref rid="R15" ref-type="bibr">15</xref>,<xref rid="R16" ref-type="bibr">16</xref>]</sup> and weighted median<sup>[<xref rid="R17" ref-type="bibr">17</xref>]</sup>methods. The IVW method was prioritized as our primary analytical strategy due to its robustness in identifying causal effects.</p><p>We intend to undertake sensitivity analyses to appraise the heterogeneity and pleiotropy, ensuring the reliability of our two-sample MR analysis results. We deployed Cochran Q test to evaluate the heterogeneity across SNPs, where a <italic toggle="yes">P</italic>-value below .05 indicates the presence of heterogeneity.<sup>[<xref rid="R18" ref-type="bibr">18</xref>,<xref rid="R19" ref-type="bibr">19</xref>]</sup> To detect pleiotropy, we used 2 approaches: the MR-Egger intercept<sup>[<xref rid="R15" ref-type="bibr">15</xref>]</sup> and the MR-PRESSO method,<sup>[<xref rid="R20" ref-type="bibr">20</xref>]</sup> considering a <italic toggle="yes">P</italic>-value under .05 as evidence of pleiotropy. We also applied MR-PRESSO to screen for outliers. In the absence of horizontal pleiotropy, the IVW analysis was deemed to be free from bias. To ensure the reliability of the observed effects of IBS on UUTC, we conducted a multivariable Mendelian Randomization (MVMR) analysis, adjusting for type 2 diabetes mellitus in the relationship between IBS and UUTC.<sup>[<xref rid="R21" ref-type="bibr">21</xref>,<xref rid="R22" ref-type="bibr">22</xref>]</sup></p><p>For our MR analysis and subsequent sensitivity assessments, we used Rstudio (Version 4.3.2) along with the TwoSampleMR R package (Version 0.5.10).</p></sec></sec><sec sec-type="results"><title>3. Results</title><sec><title>3.1. IVs selection</title><p>After completing the IV selection criteria outlined in Section 2.3, we identified 4 specific SNPs (rs10156602, rs12549729, rs7106434, rs9513519), which are detailed in Table S1, Supplemental Digital Content, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://links.lww.com/MD/N481" ext-link-type="uri">http://links.lww.com/MD/N481</ext-link>.</p></sec><sec><title>3.2. Causal impact of IBS on UUTC</title><p>The results from the IVW analysis indicate a positive association between IBS and UUTC, with an odds ratio of 1.47 and a 95% confidence interval ranging from 1.01 to 2.15, and a <italic toggle="yes">P-value</italic> of <italic toggle="yes">.0442</italic>. Both the weighted median and MR Egger methods also suggest an association between IBS and an increased likelihood of UUTC, although statistical significance was not reached, with <italic toggle="yes">P-values</italic> exceeding <italic toggle="yes">.05</italic> (Fig. <xref rid="F2" ref-type="fig">2</xref>).</p><fig position="float" id="F2" orientation="portrait"><label>Figure 2.</label><caption><p>The figure presents the outcomes of both the two-sample Mendelian Randomization analysis and the sensitivity analysis, with results considered significant at a <italic toggle="yes">P</italic>-value threshold of &lt;.05. IBS = irritable bowel syndrome; IVW = inverse variance weighting.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="medi-103-e39524-g002.jpg"/></fig></sec><sec><title>3.3. Sensitivity analysis</title><p>The sensitivity analysis indicates that for the Cochran Q test of IVW and MR-Egger methods, the <italic toggle="yes">Q</italic> values are 3.55 and 3.27, respectively, with <italic toggle="yes">P</italic>-values above .05. These results suggests no evidence of heterogeneity.</p><p>The MR-Egger intercept (<italic toggle="yes">P</italic>&#8197;=&#8197;<italic toggle="yes">.7221</italic>) provided no evidence for pleiotropy. Additionally, MR-PRESSO analysis revealed a <italic toggle="yes">P</italic>-value exceeding .05 in the global test, indicating no pleiotropic effects, and no outliers were identified (Fig. <xref rid="F2" ref-type="fig">2</xref>).</p></sec><sec><title>3.4. Multivariate MR analysis</title><p>In the multivariate MR analysis that included IBS and type 2 diabetes, it was observed that IBS also exhibited a positive association with UUTC, with an odds ratio of 1.71, a confidence interval of (1.20, 2.43), and a <italic toggle="yes">P-value</italic> of <italic toggle="yes">.0029</italic> (Fig. <xref rid="F3" ref-type="fig">3</xref>).</p><fig position="float" id="F3" orientation="portrait"><label>Figure 3.</label><caption><p>The results of the multivariate Mendelian randomization analysis suggest that IBS is a risk factor for UUTC, with results deemed significant when the <italic toggle="yes">P</italic>-value is &lt;.05.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="medi-103-e39524-g003.jpg"/></fig></sec></sec><sec sec-type="discussion"><title>4. Discussion</title><p>In a two-sample MR analysis, we found a positive association between IBS and UUTC. This correlation persisted after adjustment for type 2 diabetes in MVMR. Our MVMR analysis showed that IBS was a risk factor for UUTC. The robustness of our findings is supported by the absence of horizontal pleiotropy, as evidenced by the nonsignificant results of the MR-PRESSO global test and the Egger regression intercept, and the lack of outliers in the IVS set detected by MR-PRESSO.</p><p>Maintaining a high serum vitamin D levels could be associated with a reduced risk of stone formation or recurrence.<sup>[<xref rid="R23" ref-type="bibr">23</xref>]</sup> However, IBS patients have been found to exhibit a deficit in circulating concentrations of vitamin D.<sup>[<xref rid="R24" ref-type="bibr">24</xref>]</sup> A possible mechanism underlying the increased risk of UUTC in IBS patients is calcium-phosphate metabolic disturbances secondary to their compromised vitamin D status. Individuals suffering from IBS demonstrate higher levels of inflammatory cytokines, such as interleukin (IL)-1&#946;.<sup>[<xref rid="R25" ref-type="bibr">25</xref>]</sup> The mouse model of IBS exhibits compromised intestinal barrier function, increased permeability, and elevated systemic inflammatory markers such as IL-6 and Lipopolysaccharide.<sup>[<xref rid="R26" ref-type="bibr">26</xref>]</sup> This may be caused by intestinal barrier dysfunction in patients with IBS.<sup>[<xref rid="R27" ref-type="bibr">27</xref>]</sup> Inflammation also plays a significant role in the pathophysiology of kidney stone formation.<sup>[<xref rid="R28" ref-type="bibr">28</xref>]</sup> Oncostatin M, belonging to the IL-6 family, could enhance the development of kidney crystal deposits by directly influencing renal tubular epithelial cells and renal fibroblasts to generate molecules that bind to crystals and inflammatory cytokines.<sup>[<xref rid="R29" ref-type="bibr">29</xref>]</sup> Patients with IBS often experience symptoms of UTI.<sup>[<xref rid="R30" ref-type="bibr">30</xref>]</sup> UTI are well-recognized as significant risk factors for the development of urinary tract stones. The relationship between IBS, UTI, and urinary tract stones is worth further exploration. Patients with IBS often have accompanying unhealthy lifestyle that are closely linked to urinary stones.<sup>[<xref rid="R31" ref-type="bibr">31</xref>,<xref rid="R32" ref-type="bibr">32</xref>]</sup> Consequently, further research is needed to understand the relationship and underlying mechanisms between these 3 factors.</p><p>In our research, MR analysis proves to be an essential technique, offering a robust framework for evaluating causality and address the constraints inherent in conventional observational studies. Utilizing genetic variants as IVs, we effectively reduced the risk of confounding influences and reversed causality, enhancing the validity of the causal connection between the IBS and UUTC. However, it is imperative to recognize certain limitations. Principally, our reliance on summary-level data from large-scale GWAS may lead to biases and inherit the flaws from the original studies. Moreover, our findings are based on European populations, which restricts their applicability to other ethnic groups. Future research should aim to include diverse ethnic cohorts to confirm our results. Lastly, due to the absence of specific databases, we were unable to perform subgroup analyses on the subtypes of IBS and the composition of stones. To advance our understanding of the gut-kidney axis, further exploration through mechanistic studies and functional experiments is necessary.</p><p>Given that UUTC are the leading nonneoplastic cause of nephrectomy,<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup> identifying and implementing early preventive measures in potential at-risk groups is essential. This approach can significantly reduce patient suffering and is economically beneficial for healthcare systems. Our study results indicate that IBS is a risk factor for UUTC, highlighting the importance of vigilant monitoring for nephrolithiasis in IBS patients. This also enriches our understanding of the gut&#8211;kidney axis.<sup>[<xref rid="R33" ref-type="bibr">33</xref>]</sup></p></sec><sec><title>5. Conclusion</title><p>Our MR analysis has identified IBS as a risk factor for UUTC, enhancing our understanding of the gut&#8211;kidney axis. The specific mechanisms underlying this association merit further investigation. It provides evidence for the necessity of monitoring urinary stones in patients with IBS.</p></sec><sec><title>Acknowledgments</title><p>We would like to thank the MRC Integrative Epidemiology Unit (IEU) at the University of Bristol for creating the IEU open GWAS project and extracting the GWAS data. Our appreciation also goes to the participants and researchers involved in the FinnGen study.</p></sec><sec><title>Author contributions</title><p><bold>Conceptualization:</bold> Shang Gao, Renli Tian.</p><p><bold>Formal analysis:</bold> Shang Gao, Renli Tian.</p><p><bold>Funding acquisition:</bold> Renli Tian.</p><p><bold>Investigation:</bold> Shang Gao, Renli Tian.</p><p><bold>Methodology:</bold> Shang Gao.</p><p><bold>Project administration:</bold> Renli Tian.</p><p><bold>Supervision:</bold> Renli Tian.</p><p><bold>Validation:</bold> Shang Gao, Renli Tian.</p><p><bold>Visualization:</bold> Shang Gao, Renli Tian.</p><p><bold>Writing &#8211; original draft:</bold> Shang Gao, Renli Tian.</p><p><bold>Writing &#8211; review &amp; editing:</bold> Shang Gao, Renli Tian.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" id="s1" content-type="document" xlink:href="medi-103-e39524-s001.docx" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><fn-group><fn fn-type="abbr"><p>
<def-list><title>Abbreviations:</title><def-item><term>IBS</term><def><p>irritable bowel syndrome</p></def></def-item><def-item><term>IL</term><def><p>interleukin</p></def></def-item><def-item><term>IVs</term><def><p>instrumental variables</p></def></def-item><def-item><term>IVW</term><def><p>inverse variance weighting</p></def></def-item><def-item><term>MR</term><def><p>Mendelian randomization</p></def></def-item><def-item><term>MVMR</term><def><p>multivariable Mendelian randomization</p></def></def-item><def-item><term>UTI</term><def><p>urinary tract infections</p></def></def-item><def-item><term>UUTC</term><def><p>upper urinary tract calculi</p></def></def-item></def-list>
</p></fn></fn-group><fn-group><fn fn-type="COI-statement"><p>The authors have no funding and conflicts of interest to disclose.</p></fn><fn fn-type="other"><p>The data that support the findings of this study are available from a third party, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available.</p></fn><fn fn-type="supplementary-material"><p>Supplemental Digital Content is available for this article.</p></fn><fn fn-type="other"><p>How to cite this article: Gao S, Tian R. Mendelian insights: Irritable bowel syndrome as a predictor of upper urinary tract calculi. Medicine 2024;103:36(e39524).</p></fn></fn-group><ref-list id="r2"><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Longstreth</surname><given-names>GF</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>WG</given-names></name><name name-style="western"><surname>Chey</surname><given-names>WD</given-names></name><name name-style="western"><surname>Houghton</surname><given-names>LA</given-names></name><name name-style="western"><surname>Mearin</surname><given-names>F</given-names></name><name name-style="western"><surname>Spiller</surname><given-names>RC</given-names></name></person-group>. <article-title>Functional bowel disorders.</article-title><source>Gastroenterology</source>. <year>2006</year>;<volume>130</volume>:<fpage>1480</fpage>&#8211;<lpage>91</lpage>.<pub-id pub-id-type="pmid">16678561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2005.11.061</pub-id></mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hungin</surname><given-names>APS</given-names></name><name name-style="western"><surname>Whorwell</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Tack</surname><given-names>J</given-names></name><name name-style="western"><surname>Mearin</surname><given-names>F</given-names></name></person-group>. <article-title>The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects.</article-title><source>Aliment Pharmacol Ther</source>. <year>2003</year>;<volume>17</volume>:<fpage>643</fpage>&#8211;<lpage>50</lpage>.<pub-id pub-id-type="pmid">12641512</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1365-2036.2003.01456.x</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Francis</surname><given-names>CY</given-names></name><name name-style="western"><surname>Duffy</surname><given-names>JN</given-names></name><name name-style="western"><surname>Whorwell</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Morris</surname><given-names>J</given-names></name></person-group>. <article-title>High prevalence of irritable bowel syndrome in patients attending urological outpatient departments.</article-title><source>Dig Dis Sci</source>. <year>1997</year>;<volume>42</volume>:<fpage>404</fpage>&#8211;<lpage>7</lpage>.<pub-id pub-id-type="pmid">9052526</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1023/a:1018838507545</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mao</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xia</surname><given-names>G</given-names></name><name name-style="western"><surname>Ding</surname><given-names>Q</given-names></name></person-group>. <article-title>Urolithiasis: the most risk for nephrectomy in nonrenal tumor patients.</article-title><source>J Endourol</source>. <year>2012</year>;<volume>26</volume>:<fpage>1356</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="pmid">22809053</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/end.2012.0080</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>GD</given-names></name><name name-style="western"><surname>Ebrahim</surname><given-names>S</given-names></name></person-group>. <article-title>Mendelian randomization: prospects, potentials, and limitations.</article-title><source>Int J Epidemiol</source>. <year>2004</year>;<volume>33</volume>:<fpage>30</fpage>&#8211;<lpage>42</lpage>.<pub-id pub-id-type="pmid">15075143</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyh132</pub-id></mixed-citation></ref><ref id="R6"><label>[6]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Smith</surname><given-names>GD</given-names></name><name name-style="western"><surname>Ebrahim</surname><given-names>S</given-names></name></person-group>. <article-title>&#8220;Mendelian randomization&#8221;: can genetic epidemiology contribute to understanding environmental determinants of disease?</article-title><source>Int J Epidemiol</source>. <year>2003</year>;<volume>32</volume>:<fpage>1</fpage>&#8211;<lpage>22</lpage>.<pub-id pub-id-type="pmid">12689998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyg070</pub-id></mixed-citation></ref><ref id="R7"><label>[7]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Emdin</surname><given-names>CA</given-names></name><name name-style="western"><surname>Khera</surname><given-names>AV</given-names></name><name name-style="western"><surname>Kathiresan</surname><given-names>S</given-names></name></person-group>. <article-title>Mendelian randomization.</article-title><source>JAMA</source>. <year>2017</year>;<volume>318</volume>:<fpage>1925</fpage>&#8211;<lpage>6</lpage>.<pub-id pub-id-type="pmid">29164242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jama.2017.17219</pub-id></mixed-citation></ref><ref id="R8"><label>[8]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>S</given-names></name><name name-style="western"><surname>Larsson</surname><given-names>SC</given-names></name></person-group>. <article-title>Assessing causal associations of obesity and diabetes with kidney stones using Mendelian randomization analysis.</article-title><source>Mol Genet Metab</source>. <year>2021</year>;<volume>134</volume>:<fpage>212</fpage>&#8211;<lpage>5</lpage>.<pub-id pub-id-type="pmid">34454843</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymgme.2021.08.010</pub-id></mixed-citation></ref><ref id="R9"><label>[9]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eijsbouts</surname><given-names>C</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>T</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>NA</given-names></name><etal/></person-group>. <article-title>Genome-wide analysis of 53,400 people with irritable bowel syndrome highlights shared genetic pathways with mood and anxiety disorders.</article-title><source>Nat Genet</source>. <year>2021</year>;<volume>53</volume>:<fpage>1543</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">34741163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-021-00950-8</pub-id><pub-id pub-id-type="pmcid">PMC8571093</pub-id></mixed-citation></ref><ref id="R10"><label>[10]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xue</surname><given-names>A</given-names></name><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes.</article-title><source>Nat Commun</source>. <year>2018</year>;<volume>9</volume>:<fpage>2941</fpage>.<pub-id pub-id-type="pmid">30054458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-018-04951-w</pub-id><pub-id pub-id-type="pmcid">PMC6063971</pub-id></mixed-citation></ref><ref id="R11"><label>[11]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurki</surname><given-names>MI</given-names></name><name name-style="western"><surname>Karjalainen</surname><given-names>J</given-names></name><name name-style="western"><surname>Palta</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>FinnGen provides genetic insights from a well-phenotyped isolated population.</article-title><source>Nature</source>. <year>2023</year>;<volume>613</volume>:<fpage>508</fpage>&#8211;<lpage>18</lpage>.<pub-id pub-id-type="pmid">36653562</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-022-05473-8</pub-id><pub-id pub-id-type="pmcid">PMC9849126</pub-id></mixed-citation></ref><ref id="R12"><label>[12]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name></person-group>; <collab>CRP CHD Genetics Collaboration</collab>. <article-title>Avoiding bias from weak instruments in Mendelian randomization studies.</article-title><source>Int J Epidemiol</source>. <year>2011</year>;<volume>40</volume>:<fpage>755</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">21414999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyr036</pub-id></mixed-citation></ref><ref id="R13"><label>[13]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Slob</surname><given-names>EAW</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name></person-group>. <article-title>A comparison of robust Mendelian randomization methods using summary data.</article-title><source>Genet Epidemiol</source>. <year>2020</year>;<volume>44</volume>:<fpage>313</fpage>&#8211;<lpage>29</lpage>.<pub-id pub-id-type="pmid">32249995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gepi.22295</pub-id><pub-id pub-id-type="pmcid">PMC7317850</pub-id></mixed-citation></ref><ref id="R14"><label>[14]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name><name name-style="western"><surname>Scott</surname><given-names>RA</given-names></name><name name-style="western"><surname>Timpson</surname><given-names>NJ</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name></person-group>; <collab>EPIC- InterAct Consortium</collab>. <article-title>Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors.</article-title><source>Eur J Epidemiol</source>. <year>2015</year>;<volume>30</volume>:<fpage>543</fpage>&#8211;<lpage>52</lpage>.<pub-id pub-id-type="pmid">25773750</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10654-015-0011-z</pub-id><pub-id pub-id-type="pmcid">PMC4516908</pub-id></mixed-citation></ref><ref id="R15"><label>[15]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name></person-group>. <article-title>Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.</article-title><source>Int J Epidemiol</source>. <year>2015</year>;<volume>44</volume>:<fpage>512</fpage>&#8211;<lpage>25</lpage>.<pub-id pub-id-type="pmid">26050253</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyv080</pub-id><pub-id pub-id-type="pmcid">PMC4469799</pub-id></mixed-citation></ref><ref id="R16"><label>[16]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name></person-group>. <article-title>Interpreting findings from Mendelian randomization using the MR-Egger method.</article-title><source>Eur J Epidemiol</source>. <year>2017</year>;<volume>32</volume>:<fpage>377</fpage>&#8211;<lpage>89</lpage>.<pub-id pub-id-type="pmid">28527048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10654-017-0255-x</pub-id><pub-id pub-id-type="pmcid">PMC5506233</pub-id></mixed-citation></ref><ref id="R17"><label>[17]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Haycock</surname><given-names>PC</given-names></name><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name></person-group>. <article-title>Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.</article-title><source>Genet Epidemiol</source>. <year>2016</year>;<volume>40</volume>:<fpage>304</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">27061298</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/gepi.21965</pub-id><pub-id pub-id-type="pmcid">PMC4849733</pub-id></mixed-citation></ref><ref id="R18"><label>[18]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohen</surname><given-names>JF</given-names></name><name name-style="western"><surname>Chalumeau</surname><given-names>M</given-names></name><name name-style="western"><surname>Cohen</surname><given-names>R</given-names></name><name name-style="western"><surname>Korevaar</surname><given-names>DA</given-names></name><name name-style="western"><surname>Khoshnood</surname><given-names>B</given-names></name><name name-style="western"><surname>Bossuyt</surname><given-names>PMM</given-names></name></person-group>. <article-title>Cochran&#8217;s Q test was useful to assess heterogeneity in likelihood ratios in studies of diagnostic accuracy.</article-title><source>J Clin Epidemiol</source>. <year>2015</year>;<volume>68</volume>:<fpage>299</fpage>&#8211;<lpage>306</lpage>.<pub-id pub-id-type="pmid">25441698</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2014.09.005</pub-id></mixed-citation></ref><ref id="R19"><label>[19]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Del Greco</surname><given-names>MF</given-names></name><name name-style="western"><surname>Minelli</surname><given-names>C</given-names></name><name name-style="western"><surname>Sheehan</surname><given-names>NA</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>JR</given-names></name></person-group>. <article-title>Detecting pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome.</article-title><source>Stat Med</source>. <year>2015</year>;<volume>34</volume>:<fpage>2926</fpage>&#8211;<lpage>40</lpage>.<pub-id pub-id-type="pmid">25950993</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/sim.6522</pub-id></mixed-citation></ref><ref id="R20"><label>[20]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Verbanck</surname><given-names>M</given-names></name><name name-style="western"><surname>Chen</surname><given-names>CY</given-names></name><name name-style="western"><surname>Neale</surname><given-names>B</given-names></name><name name-style="western"><surname>Do</surname><given-names>R</given-names></name></person-group>. <article-title>Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.</article-title><source>Nat Genet</source>. <year>2018</year>;<volume>50</volume>:<fpage>693</fpage>&#8211;<lpage>8</lpage>.<pub-id pub-id-type="pmid">29686387</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-018-0099-7</pub-id><pub-id pub-id-type="pmcid">PMC6083837</pub-id></mixed-citation></ref><ref id="R21"><label>[21]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burgess</surname><given-names>S</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name></person-group>. <article-title>Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects.</article-title><source>Am J Epidemiol</source>. <year>2015</year>;<volume>181</volume>:<fpage>251</fpage>&#8211;<lpage>60</lpage>.<pub-id pub-id-type="pmid">25632051</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/aje/kwu283</pub-id><pub-id pub-id-type="pmcid">PMC4325677</pub-id></mixed-citation></ref><ref id="R22"><label>[22]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sanderson</surname><given-names>E</given-names></name><name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name><name name-style="western"><surname>Windmeijer</surname><given-names>F</given-names></name><name name-style="western"><surname>Bowden</surname><given-names>J</given-names></name></person-group>. <article-title>An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings.</article-title><source>Int J Epidemiol</source>. <year>2019</year>;<volume>48</volume>:<fpage>713</fpage>&#8211;<lpage>27</lpage>.<pub-id pub-id-type="pmid">30535378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyy262</pub-id><pub-id pub-id-type="pmcid">PMC6734942</pub-id></mixed-citation></ref><ref id="R23"><label>[23]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Z</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Associations between lumbar bone mineral density, serum 25-hydroxyvitamin D and history of kidney stones in adults aged 30&#8211;69 years in the USA (NHANES 2011&#8211;2018).</article-title><source>BMJ Open</source>. <year>2023</year>;<volume>13</volume>:<fpage>e070555</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2022-070555</pub-id><pub-id pub-id-type="pmcid">PMC10231023</pub-id><pub-id pub-id-type="pmid">37221021</pub-id></mixed-citation></ref><ref id="R24"><label>[24]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bek</surname><given-names>S</given-names></name><name name-style="western"><surname>Teo</surname><given-names>YN</given-names></name><name name-style="western"><surname>Tan</surname><given-names>XH</given-names></name><name name-style="western"><surname>Fan</surname><given-names>KHR</given-names></name><name name-style="western"><surname>Siah</surname><given-names>KTH</given-names></name></person-group>. <article-title>Association between irritable bowel syndrome and micronutrients: a systematic review.</article-title><source>J Gastroenterol Hepatol</source>. <year>2022</year>;<volume>37</volume>:<fpage>1485</fpage>&#8211;<lpage>97</lpage>.<pub-id pub-id-type="pmid">35581170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jgh.15891</pub-id></mixed-citation></ref><ref id="R25"><label>[25]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liebregts</surname><given-names>T</given-names></name><name name-style="western"><surname>Adam</surname><given-names>B</given-names></name><name name-style="western"><surname>Bredack</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Immune activation in patients with irritable bowel syndrome.</article-title><source>Gastroenterology</source>. <year>2007</year>;<volume>132</volume>:<fpage>913</fpage>&#8211;<lpage>20</lpage>.<pub-id pub-id-type="pmid">17383420</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2007.01.046</pub-id></mixed-citation></ref><ref id="R26"><label>[26]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>JH</given-names></name><name name-style="western"><surname>Jang</surname><given-names>SY</given-names></name><name name-style="western"><surname>Ahn</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Chronic gut inflammation and dysbiosis in IBS: unraveling their contribution to atopic dermatitis progression.</article-title><source>Int J Mol Sci</source>. <year>2024</year>;<volume>25</volume>:<fpage>2753</fpage>.<pub-id pub-id-type="pmid">38473999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms25052753</pub-id><pub-id pub-id-type="pmcid">PMC10931664</pub-id></mixed-citation></ref><ref id="R27"><label>[27]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hanning</surname><given-names>N</given-names></name><name name-style="western"><surname>Edwinson</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ceuleers</surname><given-names>H</given-names></name><etal/></person-group>. <article-title>Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review.</article-title><source>Therap Adv Gastroenterol</source>. <year>2021</year>;<volume>14</volume>:<fpage>1756284821993586</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1756284821993586</pub-id><pub-id pub-id-type="pmcid">PMC7925957</pub-id><pub-id pub-id-type="pmid">33717210</pub-id></mixed-citation></ref><ref id="R28"><label>[28]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Capolongo</surname><given-names>G</given-names></name><name name-style="western"><surname>Ferraro</surname><given-names>PM</given-names></name><name name-style="western"><surname>Unwin</surname><given-names>R</given-names></name></person-group>. <article-title>Inflammation and kidney stones: cause and effect?</article-title><source>Curr Opin Urol</source>. <year>2023</year>;<volume>33</volume>:<fpage>129</fpage>&#8211;<lpage>35</lpage>.<pub-id pub-id-type="pmid">36562282</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MOU.0000000000001066</pub-id></mixed-citation></ref><ref id="R29"><label>[29]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamashita</surname><given-names>S</given-names></name><name name-style="western"><surname>Komori</surname><given-names>T</given-names></name><name name-style="western"><surname>Kohjimoto</surname><given-names>Y</given-names></name><name name-style="western"><surname>Miyajima</surname><given-names>A</given-names></name><name name-style="western"><surname>Hara</surname><given-names>I</given-names></name><name name-style="western"><surname>Morikawa</surname><given-names>Y</given-names></name></person-group>. <article-title>Essential roles of oncostatin M receptor &#946; signaling in renal crystal formation in mice.</article-title><source>Sci Rep</source>. <year>2020</year>;<volume>10</volume>:<fpage>17150</fpage>.<pub-id pub-id-type="pmid">33051515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-020-74198-3</pub-id><pub-id pub-id-type="pmcid">PMC7553912</pub-id></mixed-citation></ref><ref id="R30"><label>[30]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jones</surname><given-names>R</given-names></name><name name-style="western"><surname>Latinovic</surname><given-names>R</given-names></name><name name-style="western"><surname>Charlton</surname><given-names>J</given-names></name><name name-style="western"><surname>Gulliford</surname><given-names>M</given-names></name></person-group>. <article-title>Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database.</article-title><source>Aliment Pharmacol Ther</source>. <year>2006</year>;<volume>24</volume>:<fpage>879</fpage>&#8211;<lpage>86</lpage>.<pub-id pub-id-type="pmid">16918893</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2036.2006.03044.x</pub-id></mixed-citation></ref><ref id="R31"><label>[31]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Okami</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kato</surname><given-names>T</given-names></name><name name-style="western"><surname>Nin</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Lifestyle and psychological factors related to irritable bowel syndrome in nursing and medical school students.</article-title><source>J Gastroenterol</source>. <year>2011</year>;<volume>46</volume>:<fpage>1403</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">21863219</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00535-011-0454-2</pub-id></mixed-citation></ref><ref id="R32"><label>[32]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>YC</given-names></name><name name-style="western"><surname>Hou</surname><given-names>CP</given-names></name><name name-style="western"><surname>Weng</surname><given-names>SC</given-names></name></person-group>. <article-title>Lifestyle and diet as risk factors for urinary stone formation: a study in a Taiwanese population.</article-title><source>Medicina (Kaunas)</source>. <year>2023</year>;<volume>59</volume>:<fpage>1895</fpage>.<pub-id pub-id-type="pmid">38003945</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/medicina59111895</pub-id><pub-id pub-id-type="pmcid">PMC10673421</pub-id></mixed-citation></ref><ref id="R33"><label>[33]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stavropoulou</surname><given-names>E</given-names></name><name name-style="western"><surname>Kantartzi</surname><given-names>K</given-names></name><name name-style="western"><surname>Tsigalou</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Focus on the gut-kidney axis in health and disease.</article-title><source>Front Med (Lausanne)</source>. <year>2020</year>;<volume>7</volume>:<fpage>620102</fpage>.<pub-id pub-id-type="pmid">33553216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2020.620102</pub-id><pub-id pub-id-type="pmcid">PMC7859267</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>